| Literature DB >> 26728199 |
Jean-Louis Vincent, Jacques Creteur.
Abstract
There have really been no single, major, advances in critical care medicine since the specialty came into existence. There has, however, been a gradual, continuous improvement in the process of care over the years, which has resulted in improved patient outcomes. Here, we will highlight just a few of the paradigm shifts we have seen in processes of critical care, including the move from small, closed units to larger, more open ICUs; from a paternal "dictatorship" to more "democratic" team-work; from intermittent to continuous, invasive to less-invasive monitoring; from "more" interventions to "less" thus reducing iatrogenicity; from consideration of critical illness as a single event to realization that it is just one part of a trajectory; and from "four walls" to "no walls" as we take intensive care outside the physical ICU. These and other paradigm shifts have resulted in improvements in the whole approach to patient management, leading to more holistic, humane care for patients and their families. As critical care medicine continues to develop, further paradigm shifts in processes of care are inevitable and must be embraced if we are to continue to provide the best possible care for all critically ill patients.Entities:
Mesh:
Year: 2015 PMID: 26728199 PMCID: PMC4698770 DOI: 10.1186/cc14728
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Paradigm shifts in intensive care.
| • From small, closed units to larger, more open ICUs |
| • From a paternal "dictatorship" to more democratic "teamwork" |
| • Changes in monitoring from intermittent to continuous, invasive to less invasive |
| • From too much to just enough ... |
| • Critical illness is not a single phenomenon but part of a patient's disease trajectory |
| • Expanding beyond the physical ICU structure |
| • Positive randomized controlled trials are not the only evidence |
| • Checklists are more helpful than protocols |
| • Death can be a "good" outcome |
Some interventions that have not been shown to be useful in large multicenter trials targeting mortality.
| • Tight blood glucose control |
| • Growth hormone |
| • Intraaortic balloon counterpulsation |
| • ScvO2 monitoring |
| • Glutamine administration |
| • Blood transfusions |
| • Albumin solutions |
| • Steroids in septic shock |
| • Early parenteral nutrition |
| • NOS inhibitor in septic shock |
| • Hemoglobin solution in polytrauma |
| • HES solutions for fluid therapy |
| • Glutamine supplementation |
| • Beta-stimulants in ARDS |
| • Activated protein C in sepsis |
| • Bicarbonate in metabolic acidosis |
| • High-frequency ventilation in ARDS |
| • Antioxidant supplementation |
| • Craniectomy in severe brain injury |
| • Talactoferrin in sepsis |
| • Embolectomy in stroke |
| • Pulmonary artery catheter |
ARDS acute respiratory distress syndrome, HES hydroxyethyl starch, NOS nitric oxide synthase, ScvOcentral venous oxygen saturation
Figure 1Some possible areas for protocol-based management in the ICU showing increasing difficulty of protocol, and hence likely reduced usefulness, with increasing number of variables. ARDS acute respiratory distress syndrome; DKA diabetic ketoacidosis.
The FAST-HUG checklist [34].
| • Yes/no--how many calories? | |
| • Not too much? | |
| • Can we stop it? | |
| • Unless contraindicated | |
| • Unless contraindicated | |
| • Unless contraindicated | |
| • How much insulin? |